skip to: page content | sidebar navigation | header navigation | footer navigation



Find Services \| News & Information \| Rules & Regulations \| Business Information	(Buscar)

HIV/STD Program Home

About the Program

Information For . . .

Reports

NEED MORE INFORMATION?

To locate HIV/STD testing and other services in Texas, call 2‑1‑1.

For all other HIV/STD questions, call 800-CDC-INFO (800-232-4636).

HIV/STD Web Links
U.S. HIV/STD Sites

Links to external websites are intended for informational purposes and do not have the endorsement of the Texas Department of State Health Services.

File viewing information for DSHS website.

Disease Reporting

Physicians (or a designee) are required to report any case of HIV and AIDS according to Title 25, Part 1, Chapter 97, Subchapter F, Rules §97.130- §97.134 of the Texas Administrative Code (found here ). Communicable disease reporting is exempt from HIPAA (Health Insurance Portability and Accountability Act of 1996) (for more information on HIPAA, go here).

Two forms are required. The age of the patient determines which form should be completed.

Adults and Adolescents 13 Years Old or Older:

Adult HIV/AIDS Confidential Case Report, CDC 50.42A

Please include all available information, especially regarding risk behavior.

HIV Testing History Interview Form, F13-12210 (rev. 2006-Apr 17)

Information collected on this form is required in the same manner as the CDC50.42A above. This information enables health officials to estimate the incidence of new HIV infections in Texas populations. This endeavor is critical to be able to understand and prevent the spread of HIV infection. HIV prevention and services providers rely on this information to develop effective programs. CDC has received approval from the Office of Management and Business (OMB) to require these elements from jurisdictions conducting HIV surveillance. Texas and other surveillance areas are authorized by CDC to develop state-level forms to amend the CDC50.42A to collect this information. HIV testing and healthcare providers should ask each newly diagnosed HIV-infected patient the following information to have it documented for completion of this form:

Ever had a previous positive HIV test?
Date of first positive HIV test?
Number of HIV tests in the 2 years before first positive
Ever had a negative HIV test?
Date of last negative HIV test
Date antiretroviral use began
Date antiretroviral use ended
Antiretroviral medications taken

Children 12 Years Old or Younger (including infants who are suspect cases due to maternal antibodies):

Confidential Pediatric HIV/AIDS Case Report Form, CDC 50.42B

The pediatric HIV/AIDS confidential case report form (CDC 50.42B Rev. 1/2000) is to be used to report children under 13 years of age with HIV infection, AIDS, or for children that have been perinatally exposed, but are still considered HIV indeterminate.

A case report form is to be completed for each child born to an HIV infected mother (i.e. perinatally HIV exposed). Case report forms should also be completed on:

Children that meet the pediatric AIDS case definition
Children with confirmed HIV infection
Children whose infection status has not yet been determined
Children who have seroreverted (lost maternal antibodies)

Enhanced HIV/AIDS Surveillance to Maximally Reduce Perinatal HIV Transmission (EPS) Form-Revised 8/28/2006

Data collection for Enhanced Perinatal Surveillance (EPS) will supplement information collected on both the adult and pediatric case report form and include data on prenatal care, clinical history, testing, and antiretroviral therapy. These clinical and behavioral data will be used to better monitor the effects of HIV testing, prevention, and treatment guidelines and to maximally reduce perinatal HIV transmission.

The initial EPS form will be completed within 90 days of the child's birth. Follow-up EPS forms to adequately determine the child's HIV status will be completed at 6 months, 12 months, 18 months, or until the HIV status of the child is determined.

All HIV and STD reporting forms may be obtained from the local reporting authority closest to you from the list below:

HIV Reporting Site	Name	Phone Number
Lubbock, Texas	Elena Rodriguez	806-767-0497
Amarillo, Texas	Addie Pride	806-351-7224
Arlington, Texas	Valerie Carson	817-264-4773
Dallas, Texas	Marisa Gonzales	214-819-1967
Fort Worth, Texas	Aurelio Rodgriquez	817-321-5369
Tyler, Texas	Della Mendez	903-533-5385
Galveston, Texas	Jim Hilton	409-765-2528
Houston, Texas	Jeff Meyer	713-794-9194
Temple, Texas	Norma Jones	254-778-6744
Austin, Texas	Sherry Lyles	512-972-5145
Waco, Texas	Elaine Obenoskey	254-750-5478
San Antonio, Texas	Capri Berain	210-207-8837
Midland, Texas	Oscar Hernandez	432-571-4150
El Paso, Texas	Raul Tellez	915-771-1209
Harlingen, Texas	Richard Anguiano	956-423-0130
Corpus Christi, Texas	Maria C Villarreal	361-826-7243

Helpful Links Regarding HIV and STD Reporting

Rationale for recommended changes to HIV and STD reporting rules
DSHS List of Notifiable Conditions
Overview of HIV Incidence Surveillance: [link to document that will be provided]
Overview of HIV Drug Resistance Surveillance: [link to document that will be provided]
Introduction to HIV Incidence Surveillance for Laboratories

Laboratories may report electronically to DSHS for all notifiable conditions and should Terry Donohoo or call her at (512) 533-3028 to make arrangements regarding format and security.

Last Updated September 25, 2007